Mahesh Vijaykant Nabar
Director Financiero/CFO en Unidrug Innovative Pharma Technologies Ltd. .
Perfil
Mahesh Vijaykant Nabar is currently the Chief Financial Officer at Unidrug Innovative Pharma Technologies Ltd.
He completed his undergraduate degree from the University of Rajasthan and his graduate degree from Devi Ahilya University.
Cargos activos de Mahesh Vijaykant Nabar
| Empresas | Cargo | Inicio |
|---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
 Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Director Financiero/CFO | 01/08/2018 |
Formación de Mahesh Vijaykant Nabar.
| University of Rajasthan | Undergraduate Degree |
| Devi Ahilya University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
- Bolsa de valores
- Insiders
- Mahesh Vijaykant Nabar
